🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 17 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/03/2011 | 31,01 | 31,17 | 30,93 | 31,14 | +0,31% | 0,80% | 12.905.491 |
| 22/03/2011 | 31,03 | 31,26 | 30,97 | 31,04 | +0,43% | 0,92% | 17.273.241 |
| 21/03/2011 | 30,62 | 31,09 | 30,57 | 30,91 | +1,50% | 1,68% | 15.995.834 |
| 18/03/2011 | 30,32 | 30,52 | 30,21 | 30,45 | +1,50% | 1,01% | 20.414.830 |
| 17/03/2011 | 29,83 | 30,17 | 29,73 | 30,00 | +1,16% | 1,47% | 14.366.613 |
| 16/03/2011 | 30,34 | 30,40 | 29,64 | 29,66 | -2,45% | 2,52% | 24.262.143 |
| 15/03/2011 | 30,37 | 30,57 | 30,26 | 30,40 | -1,61% | 1,04% | 16.905.602 |
| 14/03/2011 | 31,01 | 31,11 | 30,77 | 30,90 | -1,07% | 1,08% | 14.451.501 |
| 11/03/2011 | 30,98 | 31,40 | 30,98 | 31,23 | -0,52% | 1,36% | 12.846.698 |
| 10/03/2011 | 31,69 | 31,74 | 31,34 | 31,39 | -1,17% | 1,26% | 16.065.106 |
| 09/03/2011 | 31,40 | 31,95 | 31,40 | 31,77 | +0,94% | 1,73% | 14.253.848 |
| 08/03/2011 | 31,47 | 31,57 | 31,32 | 31,47 | +0,46% | 0,82% | 12.103.771 |
| 07/03/2011 | 31,49 | 31,55 | 31,22 | 31,33 | -0,70% | 1,03% | 40.392.016 |
| 04/03/2011 | 31,63 | 31,83 | 31,34 | 31,55 | -0,12% | 1,57% | 40.663.238 |
| 03/03/2011 | 31,17 | 31,73 | 31,13 | 31,58 | +1,60% | 1,93% | 39.781.451 |
| 02/03/2011 | 30,96 | 31,19 | 30,82 | 31,09 | +0,37% | 1,20% | 13.020.876 |
| 01/03/2011 | 31,11 | 31,47 | 30,95 | 30,97 | -0,34% | 1,66% | 23.209.008 |
| 28/02/2011 | 30,73 | 31,12 | 30,72 | 31,08 | +1,18% | 1,30% | 17.470.894 |
| 25/02/2011 | 30,59 | 30,78 | 30,53 | 30,72 | +0,50% | 0,81% | 9.403.180 |
| 24/02/2011 | 30,61 | 30,69 | 30,39 | 30,56 | -0,19% | 0,97% | 14.612.159 |
| 23/02/2011 | 31,03 | 31,12 | 30,57 | 30,62 | -0,77% | 1,75% | 17.581.458 |
| 22/02/2011 | 31,25 | 31,30 | 30,78 | 30,86 | -1,55% | 1,65% | 18.610.174 |
| 18/02/2011 | 31,55 | 31,69 | 31,30 | 31,35 | -0,76% | 1,24% | 17.840.418 |
| 17/02/2011 | 31,45 | 31,63 | 31,20 | 31,58 | +0,42% | 1,37% | 11.475.600 |
| 16/02/2011 | 31,24 | 31,67 | 31,18 | 31,45 | +0,52% | 1,56% | 14.758.146 |
| 15/02/2011 | 31,30 | 31,32 | 31,15 | 31,29 | -0,09% | 0,52% | 17.764.858 |
| 14/02/2011 | 31,46 | 31,51 | 31,25 | 31,32 | -0,76% | 0,82% | 13.018.990 |
| 11/02/2011 | 31,46 | 31,61 | 31,36 | 31,56 | +0,09% | 0,82% | 11.196.832 |
| 10/02/2011 | 31,60 | 31,62 | 31,38 | 31,53 | -0,15% | 0,75% | 11.355.394 |
| 09/02/2011 | 31,71 | 31,77 | 31,41 | 31,57 | -0,54% | 1,11% | 14.831.610 |